Propiedad y actividad de insiders de Cellectar Biosciences, Inc. (CLRB): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $2.35 |
| Capitalización | $19M |
| Bolsa | NASDAQ |
| País | US |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2026-07-08 | Loren Stefan | A-Award | 15,000 | $40K |
| 2026-07-07 | Kolean Chad J | A-Award | 92,000 | $289K |
| 2026-07-07 | DRISCOLL FREDERICK W | A-Award | 25,000 | $68K |
| 2026-07-07 | Chanan-Khan Asher | A-Award | 25,000 | $68K |
| 2026-07-07 | CARUSO JAMES V | A-Award | 250,000 | $785K |
| 2026-07-07 | Gu Andrew | A-Award | 25,000 | $68K |
| 2026-07-07 | Longcor Jarrod | A-Award | 118,000 | $371K |
| 2026-07-07 | Swirsky Douglas J | A-Award | 37,500 | $101K |
| 2026-07-07 | NEIS JOHN | A-Award | 25,000 | $68K |
| 2026-07-08 | Loren Stefan | A-Award | 15,000 | $40K |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $11.4M | $10.0M | $13.3M | $10.6M | $57.2M | $35.7M | $19.9M | $9.6M | $23.3M | $13.2M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $12.2M | $10.5M | $14.0M | $11.4M | $57.9M | $36.6M | $20.5M | $10.5M | $24.3M | $14.0M |
| Inmovilizado Material | $1.4M | $244713 | $543339 | $783924 | $638347 | $549135 | $978975 | $1.6M | $1.2M | $910076 |
| Fondo de Comercio | $1.7M | $1.7M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $15.3M | $12.9M | $15.1M | $12.3M | $58.7M | $37.2M | $21.6M | $12.1M | $25.5M | $15.0M |
| Cuentas por Pagar | $1.4M | $1.9M | $1.5M | $1.3M | $1.4M | $1.4M | $2.6M | $5.6M | $4.1M | $1.4M |
| Deuda a Corto | $86591 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $1.6M | $2.1M | $1.6M | $2.8M | $3.6M | $4.0M | $11.5M | $25.4M | $9.4M | $4.7M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $1.8M | $2.1M | $1.8M | $3.2M | $3.9M | $4.2M | $12.1M | $25.9M | $11.2M | $5.1M |
| Reservas | -$70.8M | -$84.3M | -$97.6M | -$111.7M | -$126.8M | -$150.9M | -$160.0M | -$202.8M | -$247.3M | -$269.1M |
| Patrimonio Neto | $13.5M | $10.8M | $13.3M | $9.1M | $54.8M | $33.0M | $9.5M | -$13.8M | $14.3M | $9.9M |
| Deuda Total | $94567 | $5249 | $2213 | $527529 | $421644 | $301741 | $603828 | $552982 | $494003 | $409586 |
| Deuda Neta | -$11.4M | -$10.0M | -$13.3M | -$10.1M | -$56.7M | -$35.4M | -$19.3M | -$9.0M | -$22.8M | -$12.8M |
| Capital Circulante | $10.6M | $8.4M | $12.3M | $8.6M | $54.4M | $32.6M | $9.0M | -$14.9M | $14.9M | $9.3M |
Salud financiera
| Deuda / Patrimonio | 0.05 |
| Ratio corriente | 6.66 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -28.56 |
Rentabilidad
| Rentabilidad sobre capital | -165.71% |
| Rentabilidad sobre capital invertido | -74.93% |
| Rentabilidad sobre activos | -60.93% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Empresas relacionadas: AEON · BOLT · CING · EVGN · IMNN · LYRA · MBIO
Explorar sector: Healthcare · Biotechnology
Más secciones de CLRB: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones